Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands.

Last updated on 23-8-2019 by Anonymous (not verified)

Peer reviewed scientific article

SCIENSANO

Abstract:

AIMS: To document progress with human papillomavirus (HPV) vaccine introduction in three closely related European countries, one with organized (the Netherlands) and two with opportunistic cervical cancer screening (Belgium and Luxembourg).METHODS: Experts involved in cervical cancer screening and national immunization programs from the three countries were contacted to provide information on the decision-making process concerning the introduction of HPV vaccine. Sales statistics were obtained from Intercontinental Marketing Services.RESULTS: Advisory boards in all three countries advised o…

Associated health topics:

QR code

QR code for this page URL